| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江西博雅生物制药股份有限公司是一家专业从事血液制品生产的定点单位.其主要产品为人血白蛋白、人免疫球蛋白、静注人免疫球蛋白(pH4)、狂犬病人免疫球蛋白、冻干静注人免疫球蛋白(pH4)、乙型肝炎人免疫球蛋白、人纤维蛋白原等3大类7个品种21个规格.且现正在研发人凝血酶原复合物和人凝血因子Ⅷ等系列产品。公司2010年被认定为国家高新技术企业,建有省级企业技术中心。 | ||||||||||||||||||||||||
| Main Business | 以血液制品为主，集生化药、化学药、原料药为辅 | ||||||||||||||||||||||||
| Legal Representative | 梁小明 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 梁化成 | ||||||||||||||||||||||||
| Solicitors | 广东信达律师事务所 | ||||||||||||||||||||||||
| Auditors | 公证天业会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0794-8264398 | ||||||||||||||||||||||||
| Fax No | 0794-8237323 | ||||||||||||||||||||||||
| Website | www.china-boya.com | ||||||||||||||||||||||||
| dongmi@china-boya.com;pengdk@china-boya.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 08/03/2012 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.470 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.300 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 14.516 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 15.521B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |